Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial

BACKGROUND: Subtle neurodegenerative motor and cognitive impairments accumulate over a prodromal period several years before clinical diagnosis of Huntington's disease (HD). The inclusion of prodromal individuals in therapeutic trials would facilitate testing of therapies early in the disease c...

Descripción completa

Detalles Bibliográficos
Autores principales: Langbehn, Douglas R., Fine, Elisabeth M., Meier, Andreas, Hersch, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306552/
https://www.ncbi.nlm.nih.gov/pubmed/35170086
http://dx.doi.org/10.1002/mds.28944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306552/
https://www.ncbi.nlm.nih.gov/pubmed/35170086
http://dx.doi.org/10.1002/mds.28944

Ejemplares similares